Skip to main content
logo
Verve Therapeutics, Inc. (VERV)
Jul 25, 2025 - VERV was delisted (reason: acquired by LLY)
11.13
0.00 (0.00%)
Inactive · Last trade price on Jul 24, 2025

Verve Therapeutics Revenue

Verve Therapeutics had revenue of $32.98M in the quarter ending March 31, 2025, with 479.03% growth. This brings the company's revenue in the last twelve months to $59.61M, up 271.44% year-over-year. In the year 2024, Verve Therapeutics had annual revenue of $32.33M with 174.98% growth.

Revenue (ttm)
$59.61M
Revenue Growth
+271.44%
P/S Ratio
16.08
Revenue / Employee
$217,566
Employees
274
Market Cap
994.14M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202432.33M20.57M174.98%
Dec 31, 202311.76M9.82M505.77%
Dec 31, 20221.94M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

VERV News

More News